Skip to main content
Premium Trial:

Request an Annual Quote

David Champagne, Jo Webber, Alexey Kondrashov, Noah Rosenberg, Robert Kavlock , Jerry Blancato

Premium

David Champagne has been named vice president and general manager of Thermo Electron's informatics business. Champagne joined Thermo in April 2003 as director of global services for Informatics and later was promoted to divisional commercial director. Previously, he worked for 13 years at Lotus Development, where he led the company's global support and service organization. Champagne succeeds Jo Webber, who recently left the company to "pursue a long-held desire to return to Europe and spend time sailing the Mediterranean," Thermo said.


The University of Michigan's Life Sciences Institute has hired several new faculty members, bringing the number of LSI faculty to 17 out of an expected total of 25-30 scientists. New recruits include Alexey Kondrashov, who joins LSI from the National Center for Biotechnology Information and will use computational systems to study evolutionary biology; and Noah Rosenberg, who is currently completing a postdoc in molecular and computational biology at the University of Southern California, and will specializes in computational analysis of population genetics and epidemiology.


The US Environmental Protection Agency announced last week that Robert Kavlock will lead its new National Center for Computational Toxicology. Kavlock, a 27-year veteran of EPA, most recently served as director of the Reproductive Toxicology Division at EPA's National Health and Environmental Effects Research Laboratory. He chaired the committee that developed the EPA's computational toxicology research program, which will now guide the center's activities. EPA also appointed Jerry Blancato, a 20-year veteran of EPA, as NCCT deputy director.

Filed under

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.